GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 124 filers reported holding GOSSAMER BIO INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,366,857 | -35.0% | 1,646,815 | -6.0% | 0.00% | -25.0% |
| Q2 2023 | $2,101,338 | -5.8% | 1,751,115 | -1.1% | 0.00% | -20.0% |
| Q1 2023 | $2,230,721 | +1.2% | 1,770,413 | +74.3% | 0.01% | 0.0% |
| Q4 2022 | $2,203,527 | -63.2% | 1,015,450 | +103.3% | 0.01% | -61.5% |
| Q3 2022 | $5,986,000 | +105.6% | 499,556 | +43.7% | 0.01% | +116.7% |
| Q2 2022 | $2,911,000 | -41.4% | 347,751 | -39.2% | 0.01% | -33.3% |
| Q1 2022 | $4,965,000 | -23.3% | 572,072 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $6,471,000 | +2574.0% | 572,072 | +2871.5% | 0.01% | +1100.0% |
| Q3 2021 | $242,000 | +55.1% | 19,252 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $156,000 | -12.4% | 19,252 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $178,000 | -41.8% | 19,252 | -39.2% | 0.00% | -50.0% |
| Q4 2020 | $306,000 | -35.7% | 31,676 | -17.4% | 0.00% | -33.3% |
| Q3 2020 | $476,000 | – | 38,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |